- Home
- INKT vs TCBS Comparison
INKT vs TCBS Comparison
Compare INKT & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INKT | TCBS |
|---|---|---|
| Founded | 2017 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 50.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INKT | TCBS |
|---|---|---|
| Price | $11.09 | $17.31 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 7.0K | 1.1K |
| Earning Date | 05-15-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | N/A | ★ 327.27 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.48 | $15.72 |
| 52 Week High | $16.80 | $20.00 |
Technical Indicators
Market Signals| Indicator | INKT | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 46.18 |
| Support Level | $10.76 | $17.23 |
| Resistance Level | $12.20 | $17.93 |
| Average True Range (ATR) | 0.66 | 0.09 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 18.31 | 12.35 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.